Using AI to support care for people with diabetes in Pakistan
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether AI-generated support can be helpful for adults living with diabetes. You may be asked to participate if you live in Pakistan and can legally consent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently live in Pakistan (in person)
- You are 18 years old or older
- You have diabetes
- You can understand and give consent to join the study
- You are not a prisoner
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether artificial intelligence can help detect early signs of diabetes-related eye damage before vision loss happens. You'd be screened at your regular doctor visit using a new AI tool, which could catch problems earlier than usual.
This study is testing a new way to encourage physical activity in people with type 2 diabetes. It uses smart phone messages to help you build a more active routine and manage your condition better.
This study tests an AI tool that helps doctors during outpatient visits. It aims to improve satisfaction for both patients and doctors.
This study tests whether an AI-powered assistant can improve satisfaction for both patients and doctors in anaesthesiology clinics. If you are visiting the clinic for the first time, you may be able to take part.
This study tests an artificial intelligence-powered mobile app to help you manage your diabetes. You'll use the app to track your health and get personalized suggestions.
This trial is testing a new AI chatbot that helps people in Hong Kong manage their health conditions like high blood sugar, high blood pressure, or high cholesterol. If you take medication for one of these conditions or care for someone who does, you may be able to join.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.